4//SEC Filing
ESBER HENRY JEMIL 4
Accession 0001437749-19-000337
CIK 0001411879other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 3:42 PM ET
Size
5.6 KB
Accession
0001437749-19-000337
Insider Transaction Report
Form 4
ESBER HENRY JEMIL
Director
Transactions
- Award
Restricted Stock Units
2019-01-02$0.07/sh+89,552$6,000→ 2,842,387 totalFrom: 2019-01-02Exp: 2029-01-02→ Common Stock (89,552 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
- [F2]The Reporting Person was granted a Restricted Stock Unit on January 2, 2019 of 50,000 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the fourth quarter of 2018 and was valued on December 31, 2018 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
- [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.
Documents
Issuer
INNOVUS PHARMACEUTICALS, INC.
CIK 0001411879
Entity typeother
Related Parties
1- filerCIK 0001391501
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 3:42 PM ET
- Size
- 5.6 KB